Human Cell and Tissue Product Safety (Shandra Eisenga Act)

Current understanding

To be populated as evidence accumulates.

Evidence log

• 2025-06-24 — Shandra Eisenga Human Cell and Tissue Product Safety Act: Bill text detail: S4885 would establish civil penalties for violations of FDA donor-eligibility and current good tissue practice rules, and direct FDA to hold a public workshop, open a stakeholder docket, report to Congress, and expand public education/transparency on HCT/Ps. (novelty: 3)
• 2026-06-24 — Shandra Eisenga Human Cell and Tissue Product Safety Act: S4885 (119th Congress), the Shandra Eisenga Human Cell and Tissue Product Safety Act, was introduced and referred to the Senate HELP Committee to address safety of human cell and tissue products; no substantive text disclosed beyond referral status. (novelty: 2)

Open questions

Related